Samtidig indgivelse af itraconazol resulterede i mere end en 10 gang forøgelse i optagelsen af simvastatinsyre (den aktive β- hydroxysyre metabolit).
Concomitant administration of itraconazole resulted in a more than 10-fold increase in exposure to simvastatin acid (the active beta-hydroxyacid metabolite).